PEG-MGF
PEG-MGF (PEGylated Mechano Growth Factor) is a heavily engineered, systemic adaptation of the natural IGF-1Ec splice variant exclusively responsible for localized trauma repair in muscle tissue. Because native MGF is destroyed in the bloodstream within mere minutes, scientists rigidly bound a Polyethylene Glycol (PEG) matrix to the peptide. This PEG conjugation shields the molecular payload, stretching its systemic half-life to several days. Administered systemically, it continuously hunts microscopic muscle tears across the entire physique, massively upregulating total-body satellite cell activation.
Quick Stats
Scientific Data
Mechanism of Action
PEG-MGF (PEGylated Mechano Growth Factor) is a modified version of MGF (IGF-1Ec) with polyethylene glycol (PEG) conjugation. Natural MGF has an extremely short half-life (~5-7 minutes), severely limiting its therapeutic use. PEGylation extends the active half-life to several days, enabling systemic distribution.
MGF is naturally produced in muscle tissue after mechanical damage (exercise via IGF-1 gene splicing). It activates satellite cells — the muscle stem cells responsible for repair and hypertrophy. PEG-MGF provides systemic satellite cell activation across all muscles, rather than requiring site-specific local injection. It does not replace protein synthesis signaling (that is IGF-1's role) — it specifically activates the muscle stem cell pool.
Source: PMID: 15735070
Background & History
PEG-MGF (Pegylated Mechano Growth Factor) is a polyethylene glycol (PEG)-modified form of MGF — itself a splice variant of IGF-1 generated in muscle tissue after mechanical stress. The PEGylation dramatically extends the half-life from ~2 minutes (native MGF peptide) to approximately 48-72 hours. MGF was discovered by Geoffrey Goldspink at University College London who showed exercise-induced local IGF-1 splice to MGF is the primary driver of satellite cell (muscle stem cell) activation and hypertrophy signaling.
Research Use Cases
- ✓Post-workout muscle hypertrophy and satellite cell activation
- ✓Recover from muscle injury with satellite cell proliferation
- ✓Cachexia: muscle wasting prevention in chronic disease
- ✓Age-related sarcopenia management
Dosing Protocol
| Typical Dose | 200-400 mcg/day |
| Frequency | 2-3× weekly |
| Half-Life | ~3-5 days (PEGylated) |
| Common Vial Sizes | 2 mg, 5 mg |
Dosing Protocols
Research Protocol
Body-Weight Dosing Reference
Estimated doses extrapolated from the published research range of 200–400 mcg/day (referenced to 70 kg / 154 lb). These are approximations — consult a qualified healthcare provider for personalised guidance.
| Weight | Low Dose | Target Dose | High Dose |
|---|---|---|---|
| 120 lb(54 kg) | 154 mcg | 231 mcg | 309 mcg |
| 140 lb(63 kg) | 180 mcg | 270 mcg | 360 mcg |
| 160 lb(73 kg) | 209 mcg | 313 mcg | 417 mcg |
| 180 lb(82 kg) | 234 mcg | 351 mcg | 469 mcg |
| 200 lb(91 kg) | 260 mcg | 390 mcg | 520 mcg |
| 220 lb(100 kg) | 286 mcg | 429 mcg | 571 mcg |
| 250 lb(113 kg) | 323 mcg | 484 mcg | 646 mcg |
💉 For exact syringe units based on your vial concentration, use the PEG-MGF Reconstitution Calculator →
Administration
Expected Timeline
Who Is It For?
Muscle Recovery / Satellite Cell Activation
LowExtends MGF's extremely short half-life. Provides systemic satellite cell signaling vs. local MGF injection.
Hypertrophy Support
LowActivates muscle stem cells. Best stacked with IGF-1 LR3 or GH secretagogues for additive effects.
Reconstitution Example
Safety & Considerations
Research peptide. PEG modification may cause immune sensitization in rare cases (anti-PEG antibodies). Start with lower doses. Not recommended for individuals with active cancers due to growth factor properties.
Regulatory & Legal Status
Not currently on the WADA 2026 Prohibited List. Policies may change — verify before competition.
Research Chemical
US Compounding: Not eligible / not available
⚠️ This information is for educational purposes only and may not reflect the most current regulatory updates. Always verify with official FDA, WADA, and jurisdiction-specific sources before use.
Interactions & Contraindications
Localized satellite cell activation — inject near the muscle group targeted. PEG moiety may cause antibody formation with very long-term repeated use (PEG immunogenicity). Hypoglycemia risk at very high doses via IGF-1-like receptor activation. Contraindicated with active cancer.
Synergies & Common Stacks
MGF activates satellite cells locally; IGF-1 LR3 drives systemic anabolic signaling via the IGF-1 receptor. Sequence them: PEG-MGF post-workout, IGF-1 LR3 follows to drive the cells that MGF activated.
BPC-157 repairs the vascular and structural components; PEG-MGF drives satellite cell proliferation for muscle-specific repair. Complete muscle injury recovery stack.
Dosing Quick Reference
Frequently Asked Questions
What is the difference between MGF and PEG-MGF?▼
When should I inject PEG-MGF?▼
References
- Goldspink G “"Mechano growth factor: a tissue specific anabolic growth factor".” Biochemical Society Transactions (2002). PMID: 12196225
📚 Related Articles
Looking for a trusted source? See our recommended suppliers →
Independently tested · COA-verified · Save 10% with our exclusive code